What is Cullinan Therapeutics, Inc.'s investments?

Cullinan Therapeutics, Inc. (CGEM) reported investments of $38.5M in Q1 2026.

How has Cullinan Therapeutics, Inc.'s investments changed year-over-year?

Cullinan Therapeutics, Inc.'s investments decreased by 85.2% year-over-year, from $259.39M to $38.5M.

Cullinan Therapeutics, Inc. CGEM Investments

Investments at other companies

Eli LillyLLY

——

Dianthus TherapeuticsDNTH

——

Other financials

Income statement

See full

Revenue-—

Operating income-$53.7M+2.4%

Net income-$49.7M-2.4%

EPS (diluted)-$0.69+24.2%

Balance sheet

See full

Cash & equivalents$75.1M-2.1%

Total debt$2.4M+29.5%

Total equity$408.7M-30.8%

Total assets$403.0M-30.5%

Cash flow

See full

Operating cash flow-$46.0M-6.7%

CapEx$11.0K—

Free cash flow-$38.1M-4.1%

Valuation

See full

Market cap$1.08B+151%

Enterprise value$1.01B+181%

Profitability

See full

Operating margin-358.7%—

Net margin-346.1%—

Returns & leverage

See full

Return on equity-44%+26.2pp

Debt / equity0×0.0×

Current ratio10.3×-1.3×

Where this comes from

Reported directly by Cullinan Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermInvestments.

The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cullinan Therapeutics, Inc.'s investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cullinan Therapeutics, Inc.'s investments?: Cullinan Therapeutics, Inc. (CGEM) reported investments of $38.5M in Q1 2026.
How has Cullinan Therapeutics, Inc.'s investments changed year-over-year?: Cullinan Therapeutics, Inc.'s investments decreased by 85.2% year-over-year, from $259.39M to $38.5M.